miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene.
JSON
Tsouko E, Wang J, Frigo DE, Aydoğdu E, Williams C
Carcinogenesis 36 (9) 1051-1060 [2015-09-00; online 2015-06-18]
Triple-negative breast cancer (TNBC) is characterized by aggressiveness and affects 10-20% of breast cancer patients. Since TNBC lacks expression of ERα, PR and HER2, existing targeted treatments are not effective and the survival is poor. In this study, we demonstrate that the tumor suppressor microRNA miR-200a directly regulates the oncogene EPH receptor A2 (EPHA2) and modulates TNBC migration. We show that EPHA2 expression is correlated with poor survival specifically in basal-like breast cancer and that its expression is repressed by miR-200a through direct interaction with the 3'UTR of EPHA2. This regulation subsequently affects the downstream activation of AMP-activated protein kinase (AMPK) and results in decreased cell migration of TNBC. We establish that miR-200a directs cell migration in a dual manner; in addition to regulating the well-characterized E-cadherin pathway it also regulates a EPHA2 pathway. The miR-200a-EPHA2 axis is a novel mechanism highlighting the possibility of utilizing miR-200a delivery to target TNBC metastases.
PubMed 26088362
DOI 10.1093/carcin/bgv087
Crossref 10.1093/carcin/bgv087
pii: bgv087
pmc: PMC5975720